NCT00070850View on ClinicalTrials.gov

Prenatal Screening For Smith-Lemli-Opitz Syndrome

CompletedOBSERVATIONAL
Enrollment

1,800

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

July 31, 2005

Conditions
Smith-Lemli-Opitz SyndromePregnancy
Trial Locations (1)

04074

Foundation for Blood Research, Scarborough

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00070850 - Prenatal Screening For Smith-Lemli-Opitz Syndrome | Biotech Hunter | Biotech Hunter